开发教育材料,以帮助阿尔茨海默病血液生物标志物披露
Raymond R Romano1,2, Dominic Roby1, Sydney Wilhoite1
1Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center Nashville Tennessee USA.
Alzheimer's & dementia (New York, N. Y.)
|November 20, 2025
概括
教育材料有效地传达阿尔茨海默病 (AD) 痴呆风险从血化陶 (p-tau) 血液检测到轻度认知障碍 (MCI) 患者. 参与者发现价值,但希望更多的风险降低信息.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 临床诊断 临床诊断 临床诊断
背景情况:
- 阿尔茨海默病 (AD) 血液生物标志物的临床使用需要有效的结果披露方法.
- 化 (p-tau) 是AD痴呆风险的关键血液生物标志物.
- 开发以患者为中心的沟通工具对于生物标志物实施至关重要.
研究的目的:
- 根据血p-tau结果开发和评估教育材料,以披露痴呆风险.
- 了解轻度认知障碍 (MCI) 患者及其护理伙伴之间的痴呆风险披露的沟通偏好.
主要方法:
- 混合方法研究,涉及重点小组与被诊断患有MCI的个人及其护理伙伴.
- 对焦小组成绩单进行主题分析,以确定关键主题和偏好.
- 评估教育材料的实用性和理解性.
主要成果:
- 参与者对教育材料的价值和理解性进行了高度评价.
- 专题分析显示,参与者对痴呆症进展和术语感到困惑.
- 参与者表示他们更喜欢多种多样的通信方式,并寻求额外的风险降低信息.
结论:
- 教育材料有助于通过血p-tau向患有MCI的个体透露AD痴呆风险.
- 解决有关痴呆症进展和术语的困惑是很重要的.
- 结合降低风险的策略和视觉沟通可以增强理解.
相关概念视频
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K